TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.62$ -15.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACTU
Line item 2022 2023 2024 2025
– – – –
– -35.2% +371.2% +203.0%
– +48.6% -57.2% -376.8%
– – – –
– – – –
– – – -100.0%
– -78.5% +565.8% -13.8%
– -1,296.8% – -20.5%
– – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?